Tweets
Inflammatory bowel disease in spondyloarthritis - does it matter?
Do the clinical features of axSpA patients with and without IBD differ?
https://t.co/t0wJRXXH0a https://t.co/iZsiP1AgWh
Dr. John Cush @RheumNow ( View Tweet )
1 year 7 months ago
Missed the Live #EULAR2024 #lupus #SLE Topic Recap session yesterday? You can catch up using the link below.
https://t.co/NYJgNb5ME0
@RheumNow @andreafava https://t.co/eeoSux6Csl
Links:
Md Yuzaiful Md Yusof @Yuz6Yusof ( View Tweet )
1 year 7 months ago
Voclosporin and Steroids in Lupus Nephritis
Dr. Jack Cush reports on abstract OP0059 presented at Eular 2024 in Vienna, Austria.
https://t.co/y9QPieV0py https://t.co/GzwntEJLve
Dr. John Cush @RheumNow ( View Tweet )
1 year 7 months ago
Mechanistic Promise in RA Doesn’t Always Mean Actual Gain
Dr. David Liew reports on abstracts OP0007 and OP0069 at Eular 2024 in Vienna, Austria.
https://t.co/PcKtezJLCH https://t.co/N9tdgFN7Xq
Links:
Dr. John Cush @RheumNow ( View Tweet )
1 year 7 months ago
EULAR 2024: Monday’s Topic Panel (SLE) with RheumNow https://t.co/Ozl1DZKMuL
Links:
Dr. John Cush @RheumNow ( View Tweet )
1 year 7 months ago
3 Big Lupus Themes from EULAR 2024
Dr. Janet Pope discusses three hot topics in lupus at Eular 2024 in Vienna, Austria, including abstracts POS0732 and OP0255.
https://t.co/XD1EJW2nNE https://t.co/jALVfebb8t
Dr. John Cush @RheumNow ( View Tweet )
1 year 7 months ago
Dual seropositivity and shared epitopes in RA: friends or foes?
Dual seropositivity, RF and/or anti-citrullinated protein antibodies (ACPA) as well as shared epitope (SE) are known to be associated with poor prognosis and structural damage in RA.
https://t.co/QcTHpgPV2Q https://t.co/TzueMr8M5T
Dr. John Cush @RheumNow ( View Tweet )
1 year 7 months ago
Belimumab’s Sustained Impact in Lupus
SLE a chronic autoimmune multi-system inflammatory condition, can present with various, sometimes severe, clinical manifestations, leading to high levels of morbidity including impact on quality of life.
https://t.co/4Gf5SJN5FG https://t.co/LxCjLQkaYQ
Dr. John Cush @RheumNow ( View Tweet )
1 year 7 months ago
Can we prevent psoriatic arthritis?
PsA affects up to 30% of PsO patients. Understanding factors that lead to PsA helps in early interventions. Most PsA patients have preceding PsO.
https://t.co/03H4YrvxMe https://t.co/efUVaccSHn
Dr. John Cush @RheumNow ( View Tweet )
1 year 7 months ago
Summary of #EULAR2024 #ClinicalPearls
JAKi have expanding disease data
✅ #GCA w #UPA
✅ Awaiting data in #SLE w #UPA & #Deucravacitinib
✅Use in #JIA
✅No new safety signals
@rheumnow
@eular_org
Janet Pope @Janetbirdope ( View Tweet )
1 year 7 months ago
EULAR 2024: New drugs for RA?
Abiprubart is an Abatacept distant relative, targeting T cell activation through a different target/molecular interaction (CD40/CD154).
https://t.co/3wAGjfCdcN https://t.co/2YK2OeIVZK
Dr. John Cush @RheumNow ( View Tweet )
1 year 7 months ago
EULAR 2024 - Day 1 Report
https://t.co/LpYxUP8d7e https://t.co/5zwc0HsZZ8
Dr. John Cush @RheumNow ( View Tweet )
1 year 7 months ago
